Utilization of Methylnaltrexone (Relistor) For Opioid-Induced Constipation in an Oncology Hospital

Disclosure: The authors report no financial or commercial relationships in regard to this article. This manuscript was supported in part by the National Institutes of Health through M.D. Anderson’s Cancer Center Support Grant, CA 016672.